Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 13, 2024

SELL
$26.13 - $33.94 $85,445 - $110,983
-3,270 Reduced 20.41%
12,755 $367,000
Q3 2023

Nov 14, 2023

SELL
$32.09 - $37.51 $17,649 - $20,630
-550 Reduced 3.32%
16,025 $531,000
Q2 2023

Aug 11, 2023

SELL
$36.12 - $41.79 $1,805 - $2,089
-50 Reduced 0.3%
16,575 $607,000
Q1 2023

May 10, 2023

BUY
$39.39 - $51.28 $129,987 - $169,224
3,300 Added 24.77%
16,625 $678,000
Q4 2022

Feb 09, 2023

SELL
$41.75 - $54.5 $1,043 - $1,362
-25 Reduced 0.19%
13,325 $683,000
Q3 2022

Nov 08, 2022

SELL
$43.76 - $53.42 $8,752 - $10,684
-200 Reduced 1.48%
13,350 $584,000
Q2 2022

Jul 19, 2022

SELL
$46.53 - $55.17 $13,772 - $16,330
-296 Reduced 2.14%
13,550 $711,000
Q1 2022

May 17, 2022

SELL
$45.75 - $56.69 $6,862 - $8,503
-150 Reduced 1.07%
13,846 $717,000
Q3 2021

Nov 10, 2021

SELL
$39.25 - $50.42 $7,850 - $10,084
-200 Reduced 1.41%
13,996 $601,000
Q2 2020

Jul 28, 2020

SELL
$30.12 - $36.54 $3,012 - $3,654
-100 Reduced 0.7%
14,196 $464,000
Q1 2020

May 07, 2020

SELL
$27.03 - $38.62 $2,703 - $3,861
-100 Reduced 0.69%
14,296 $467,000
Q3 2019

Nov 06, 2019

SELL
$32.49 - $42.13 $18,421 - $23,887
-567 Reduced 3.79%
14,396 $517,000
Q2 2019

Jul 24, 2019

SELL
$36.98 - $41.52 $39,753 - $44,634
-1,075 Reduced 6.7%
14,963 $648,000
Q1 2019

May 01, 2019

SELL
$37.5 - $41.2 $9,375 - $10,300
-250 Reduced 1.53%
16,038 $681,000
Q3 2018

Oct 15, 2018

SELL
$34.47 - $41.81 $3,447 - $4,181
-100 Reduced 0.61%
16,288 $718,000
Q2 2018

Jul 30, 2018

SELL
$32.98 - $35.16 $22,261 - $23,732
-675 Reduced 3.96%
16,388 $595,000
Q1 2018

Apr 24, 2018

SELL
$31.91 - $37.02 $24,730 - $28,690
-775 Reduced 4.34%
17,063 $606,000
Q4 2017

Feb 02, 2018

BUY
$33.26 - $35.29 $202,486 - $214,845
6,088 Added 51.81%
17,838 $645,000
Q3 2017

Oct 26, 2017

BUY
$31.0 - $34.15 $364,250 - $401,262
11,750
11,750 $419,000

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $149B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Puzo Michael J Portfolio

Follow Puzo Michael J and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Puzo Michael J, based on Form 13F filings with the SEC.

News

Stay updated on Puzo Michael J with notifications on news.